OXIGENE INC
10-Q, EX-27.1, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: OXIGENE INC, 10-Q, 2000-08-14
Next: PMC COMMERCIAL TRUST /TX, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE>                     5
<CIK>                         0000908259
<NAME>                        OXiGENE, INC.
<MULTIPLIER>                  1,000

<S>                           <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>                           DEC-31-2000
<PERIOD-START>                              JAN-01-2000
<PERIOD-END>                                JUN-30-2000
<CASH>                                           31,143
<SECURITIES>                                      2,267
<RECEIVABLES>                                         0
<ALLOWANCES>                                          0
<INVENTORY>                                           0
<CURRENT-ASSETS>                                 34,159
<PP&E>                                              314
<DEPRECIATION>                                     (139)
<TOTAL-ASSETS>                                   36,897
<CURRENT-LIABILITIES>                             1,386
<BONDS>                                               0
                                 0
                                           0
<COMMON>                                            113
<OTHER-SE>                                       26,884
<TOTAL-LIABILITY-AND-EQUITY>                     36,897
<SALES>                                               0
<TOTAL-REVENUES>                                  2,108
<CGS>                                                 0
<TOTAL-COSTS>                                         0
<OTHER-EXPENSES>                                  6,423
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                    0
<INCOME-PRETAX>                                  (4,315)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                              (4,315)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                     (4,315)
<EPS-BASIC>                                       (0.38)
<EPS-DILUTED>                                     (0.38)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission